Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities.
Adult
Agenesis of Corpus Callosum
/ diagnostic imaging
Cerebellum
/ abnormalities
Child
Child, Preschool
Female
Humans
Hydrolases
/ chemistry
Intellectual Disability
/ diagnostic imaging
Male
Microtubule-Associated Proteins
/ chemistry
Models, Molecular
Mutation, Missense
/ genetics
Neurodevelopmental Disorders
/ diagnostic imaging
Tubulin
/ metabolism
Young Adult
DPYSL5
brain malformation
corpus callosum agenesis
de novo missense variants
dendrite branching
neurodevelopmental disorder
primary neuronal cultures
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
06 05 2021
06 05 2021
Historique:
received:
23
12
2020
accepted:
01
04
2021
pubmed:
25
4
2021
medline:
1
7
2021
entrez:
24
4
2021
Statut:
ppublish
Résumé
The collapsin response mediator protein (CRMP) family proteins are intracellular mediators of neurotrophic factors regulating neurite structure/spine formation and are essential for dendrite patterning and directional axonal pathfinding during brain developmental processes. Among this family, CRMP5/DPYSL5 plays a significant role in neuronal migration, axonal guidance, dendrite outgrowth, and synapse formation by interacting with microtubules. Here, we report the identification of missense mutations in DPYSL5 in nine individuals with brain malformations, including corpus callosum agenesis and/or posterior fossa abnormalities, associated with variable degrees of intellectual disability. A recurrent de novo p.Glu41Lys variant was found in eight unrelated patients, and a p.Gly47Arg variant was identified in one individual from the first family reported with Ritscher-Schinzel syndrome. Functional analyses of the two missense mutations revealed impaired dendritic outgrowth processes in young developing hippocampal primary neuronal cultures. We further demonstrated that these mutations, both located in the same loop on the surface of DPYSL5 monomers and oligomers, reduced the interaction of DPYSL5 with neuronal cytoskeleton-associated proteins MAP2 and βIII-tubulin. Our findings collectively indicate that the p.Glu41Lys and p.Gly47Arg variants impair DPYSL5 function on dendritic outgrowth regulation by preventing the formation of the ternary complex with MAP2 and βIII-tubulin, ultimately leading to abnormal brain development. This study adds DPYSL5 to the list of genes implicated in brain malformation and in neurodevelopmental disorders.
Identifiants
pubmed: 33894126
pii: S0002-9297(21)00135-X
doi: 10.1016/j.ajhg.2021.04.004
pmc: PMC8206156
pii:
doi:
Substances chimiques
MAP2 protein, human
0
Microtubule-Associated Proteins
0
TUBB3 protein, human
0
Tubulin
0
DPYSL5 protein, human
EC 3.-
Hydrolases
EC 3.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
951-961Subventions
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS119263
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS058721
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050375
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Informations de copyright
Copyright © 2021 American Society of Human Genetics. All rights reserved.
Références
Sci Rep. 2017 Sep 6;7(1):10681
pubmed: 28878401
Cell Mol Life Sci. 2018 Jan;75(1):67-79
pubmed: 28864883
Neurochem Int. 2020 Oct;139:104795
pubmed: 32652266
J Med Genet. 2013 Dec;50(12):819-22
pubmed: 24065355
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Acta Neuropathol. 2021 Feb;141(2):139-158
pubmed: 33226471
J Neurosci. 2001 Sep 15;21(18):7203-14
pubmed: 11549731
Am J Med Genet A. 2005 Apr 1;134A(1):3-11
pubmed: 15704124
Nature. 2014 Nov 13;515(7526):209-15
pubmed: 25363760
J Biol Chem. 2000 Dec 1;275(48):37957-65
pubmed: 10956643
Curr Opin Genet Dev. 2020 Dec;65:195-206
pubmed: 32846283
Cell Mol Life Sci. 2021 Mar;78(6):2517-2563
pubmed: 33263776
J Comp Neurol. 2005 May 23;486(1):1-17
pubmed: 15834957
Commun Integr Biol. 2010 Mar;3(2):172-5
pubmed: 20585514
Brain. 2014 Jun;137(Pt 6):1579-613
pubmed: 24477430
Front Cell Neurosci. 2020 Jun 23;14:188
pubmed: 32655376
Am J Hum Genet. 2019 Sep 5;105(3):606-615
pubmed: 31474318
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
J Neurochem. 2013 Jun;125(6):855-68
pubmed: 23373749
Neuropharmacology. 2019 Oct;157:107673
pubmed: 31233825
Eur J Hum Genet. 2015 May;23(5):633-8
pubmed: 24916641
J Med Genet. 2020 Apr;57(4):245-253
pubmed: 31712251
Mol Psychiatry. 2015 Sep;20(9):1037-45
pubmed: 26077693
Mol Neurobiol. 2003 Aug;28(1):51-64
pubmed: 14514985
J Neurosci. 2011 Feb 2;31(5):1773-9
pubmed: 21289187
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
J Neurosci. 2010 Aug 11;30(32):10639-54
pubmed: 20702696
Brain Sci. 2020 Sep 09;10(9):
pubmed: 32916978
J Neurochem. 2006 Apr;97 Suppl 1:16-23
pubmed: 16635246
Science. 2020 Nov 13;370(6518):
pubmed: 33184181
Pediatrics. 2019 Oct;144(4):
pubmed: 31558576
Am J Med Genet. 1987 Feb;26(2):481-91
pubmed: 3812597
Acta Biomed. 2020 Nov 09;91(13-S):e2020003
pubmed: 33170170
Neurobiol Dis. 2020 Mar;136:104709
pubmed: 31843706
Sci Rep. 2017 Dec 1;7(1):16812
pubmed: 29196732